Search Results

4301 - 4325 of 56021
TitleWireDateTime
CN Reports Strong First Quarter Operational and Commercial Performance Globe Newswire 04/29 07:30
ORBCOMM® refinances existing debt facility and secures capital to accelerate market leadership Globe Newswire 04/29 07:30
Nexxen to Announce First Quarter 2026 Financial Results on May 13, 2026 Globe Newswire 04/29 07:30
Habit Celebrates Newest Restaurant Launch in Sunny Huntington Beach Globe Newswire 04/29 07:30
Chagee Files Its 2025 Annual Report on Form 20-F Globe Newswire 04/29 07:15
Sagtec Global Limited Achieves Record Revenue of US$19.1 Million in Fiscal Year 2025, Marking 49% Year-over-Year Growth Globe Newswire 04/29 07:15
Verisk Reports First Quarter 2026 Financial Results Globe Newswire 04/29 07:15
Kornit Digital Sets First Quarter 2026 Earnings Release Date and Webcast Globe Newswire 04/29 07:05
Anika Reports First Quarter 2026 Financial Results Globe Newswire 04/29 07:05
Cerro de Pasco Resources Announces Upgrade to OTCQX Best Market Globe Newswire 04/29 07:02
Amarin Reports 2026 First Quarter Financial Results Globe Newswire 04/29 07:00
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution Globe Newswire 04/29 07:00
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May Globe Newswire 04/29 07:00
OMNI-LITE INDUSTRIES REPORTS FOURTH QUARTER AND FISCAL 2025 RESULTS Globe Newswire 04/29 07:00
Luckin Coffee Announces First Quarter 2026 Financial Results and Share Repurchase Program Globe Newswire 04/29 07:00
Avis Budget Group Reports First Quarter 2026 Results Globe Newswire 04/29 07:00
PyroGenesis Provides Corporate Update on NexGen™ Titanium Metal Powder Strategy Globe Newswire 04/29 07:00
Coastal Financial Corporation Announces First Quarter 2026 Results Globe Newswire 04/29 07:00
The Chefs’ Warehouse Reports First Quarter 2026 Financial Results Globe Newswire 04/29 07:00
X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union Globe Newswire 04/29 07:00
Capital Power reports first quarter 2026 results, underpinned by strong flexible generation performance and continued contracting success Globe Newswire 04/29 07:00
Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD Globe Newswire 04/29 07:00
Oatly Reports First Quarter 2026 Financial Results Globe Newswire 04/29 07:00
DoubleDown Confirms Receipt of a Non-Binding Expression of Interest from Controlling Shareholder, DoubleU Games, to Acquire all Outstanding Common Shares and ADSs Globe Newswire 04/29 07:00
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium at Johns Hopkins University Globe Newswire 04/29 07:00
4301 - 4325 of 56021

News, Photo and Web Search